Standardized Approach Needed to Evaluate Neuropathic Cancer Pain
A standardized approach is vital for the assessment of neuropathic cancer pain in order to improve treatment results and future clinical/pre-clinical studies.
Cancer
Sodium Thiosulfate Receives Priority Review for Prevention of Cisplatin-Induced Ototoxicity
The application is supported by data from 2 pivotal open-label, randomized phase 3 trials (SIOPEL 6 and ACCL0431), which compared the efficacy of sodium thiosulfate plus cisplatin to cisplatin alone for the prevention of cisplatin-induced hearing loss.
Bendamustine-Rituximab Combination for Immuno-Mediated Neuropathies
Combination of bendamustine with rituximab treatment may be an effective regimen for immune-mediated neuropathies associated with hematologic malignancy.
Smartphone, Web App May Help Predict Prognosis for Meningioma
An open-source smartphone and web application has been developed to help predict clinical malignancy and survival outcomes for meningioma.
Acupuncture Proved More Effective Than Standard Care in Reducing Radiation-Induced Xerostomia
True acupuncture is more effective than placebo and standard care in reducing the number and severity of radiation-induced xerostomia (dry mouth) symptoms at 1 year following treatment in patients with head and neck cancer.
Acupuncture and Acupressure May Aid in Pain Management for Patients With Cancer
Researchers found the use of acupuncture and/or acupressure is associated with reduced cancer pain and decreased use of analgesics.
Non-melanoma Skin Cancers Are Less Likely to be Treated in Elderly Patients
Unlike previous studies, the researchers found that in their practice, no-treatment rates between elderly and nonelderly patients with biopsy-proven NMSCs were significantly different.
Behavioral Therapy Helps Reduce Insomnia in Cancer Survivors
A stepped care approach seems beneficial for insomnia treatment among cancer survivors.
Highly Sensitive Imaging for the Characterization of Nerve Sheath Tumors in NF1
A study finds that in characterization of peripheral nerve sheath tumors as benign or malignant in patients with neurofibromatosis type 1, MRI-obtained apparent diffusion coefficient and FDG-PET/CT-obtained maximum standardized uptake values are excellent imaging markers.
Darzalex Gets Approval for Additional Multiple Myeloma Indication
The FDA has expanded the approval of Darzalex (daratumumab; Janssen Biotech) to include use in combination with lenalidomide and dexamethasone in patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplant.
-
Loading...
-
Loading...
Next post in General Neurology
